Document:

Consulting Agreement with L. Jacobs

 Exhibit 10.11 
 CONSULTING AGREEMENT WITH L. JACOBS 
 January 24, 2006 
 Dr. Leonard S. Jacob 
 803 Oxford Crest 
 Villanova, PA 19085 
  

	Re:	Consulting Agreement 

 Dear Len, 
 The purpose of this letter is to amend and restate the terms of a consulting agreement between you and GLYCONIX CORP. (hereinafter, together with its
subsidiaries and affiliates, referred to as the “Company”) dated October 31, 2005. The Company wishes to engage you to serve the Company as a consultant, functioning as an independent contractor and not an employee of the Company.

 The period of the consulting will be, as the Company deems necessary and may be terminated by either party with one hundred twenty
(120) days notice. Consultation will take place at times and places mutually agreed upon by you and representatives of the Company. 
 In consideration for your consulting services, the Company agrees to pay you in accordance with services rendered, $25,000 per year. 
 In addition to the above consulting fee, the Company will reimburse you your reasonable out-of-pocket expenses (airline travel consistent with the Company personnel airline travel. 
 As recognition of your significant role in the Company’s fundraising process, you will receive an advisory fee as follows: 
 A. The Company will transfer to your name as a gift 100,000 shares of the Company’s common stock; 
 B. 
  

	 	•	 	2% in cash of any funds raised up to $10 million; 

  

	 	•	 	1.5% in cash of any funds raised in excess of $10 million but less than $20 million; 

  

	 	•	 	1% in cash of any fund raised in excess of $20 million; 

 C. 1% of the outstanding shares of the Company’s common stock when a minimum of $5 million is raised. 
 The Company
understands that you are available to perform the consulting services as provided herein and that you warrant that this will not cause a direct conflict of interest because of your relationship with the Company, any other research facility or any
other corporate entity or because of work you may have undertaken with others. It is not the Company’ desire to be afforded access to information which is confidential or in any way proprietary to any third party, nor to receive any information
the receipt of which implies any obligations. You warrant that during the time period of your retainer as a consultant under this agreement, you will not knowingly enter into any agreement or relationship to render services as an employee of,
adviser or consultant to any other individual, firm or corporation that would be inimical to or in direct conflict with those aspects of the Company’s business, the development of glycosylated derivatives of drugs for the treatment of various
diseases and sugar-drug complexes and their derivatives for use in boron neutron capture therapy, to which this agreement relates. This agreement does not prevent you from engaging in ongoing and future consultancies, particularly in the fields of
oncology, infectious disease or gastrointestinal diseases. You further warrant that no other party has any right, title or interest to any information, ideas, developments and inventions which may be submitted to the Company by you in your capacity
as the Company’ consultant. 
 During your engagement as a consultant, it may be necessary for you to have access to certain the
Company’s technical information and material. You agree to consider such information as confidential and agree to take all reasonable precautions to prevent disclosure of any such information to third parties. You also agree not to use such

 
information or materials without the Company’ express written consent. These obligations of confidentiality and non-use shall continue beyond the term
of this agreement and shall automatically terminate five (5) years from the effective date of this agreement, but shall cease to apply as to any specific portion of the Company information or material which is or becomes available to the public
through no fault on your part. 
 You agree to disclose promptly and fully to the Company all creative ideas, developments and inventions
conceived or reduced to practice by you as a direct result of your consulting work with the Company. All such ideas, developments and inventions shall be the property of the Company, and accordingly, you agree to assign to the Company the entire
rights, title and interests to such ideas, developments and inventions, without payment other than the consulting fee provided herein. Furthermore, you agree to execute any and all documents, which the Company deems necessary or convenient to fully
implement its proprietary rights in any such ideas, developments and inventions, at no expense to you. 
 The Company wishes to retain the
results of your consulting work as confidential. Therefore, you agree not to publish or otherwise disclose the results of your consulting work without the express written consent of the Company. In the event that the Company in the scientific
literature publishes work resulting from your consulting, acknowledgement will be made to you in the appropriate accepted style. 
 The
Company will indemnify and hold you harmless from and against any and all losses, liabilities, damages, expenses and costs (including reasonable attorney’s fees) (“Losses”) asserted by third parties in connection with or arising out
of your rendering of services hereunder except to the extent that such Losses were directly caused by or resulted from (i) your breach of this agreement or (ii) the gross negligence or willful misconduct on your part. You will notify the
Company promptly upon learning of a claim, demand, suit, or proceeding that might give rise to a Loss, and the Company may control defense and settlement thereof provided it does so diligently, in good faith and using reasonably experienced counsel
with expertise in the relevant field. You will reasonably cooperate in such defense and/or settlement at the Company’s request and may participate at your own expense using your own counsel. 
 This agreement constitutes the entire understanding between the parties and may be amended by a written instrument executed by both parties and
specifically entitled an amendment of this agreement. 
 The laws of the State of New York, U.S.A, shall govern the terms and conditions of
this agreement. 
 If the terms of this agreement meet with your approval, please sign and date both copies of this agreement and return one
to the Company and keep the other for your files. This consulting agreement will become effective on the date hereinabove written. 
  

									
		 		 	 Very truly yours,

		 		 	 February 7, 2006

				
		 		 	 By:
	 	 /s/ J. R. LeShufy

		 		 		 		 	 J. R. LeShufy

		 		 		 		 	 Executive Vice President , Secretary

			
	 ACKNOWLEDGED, ACCEPTED
 AND AGREED TO:
	 		 	
		 		 	 February 7, 2006

				
		 		 	 By:
	 	 /s/ Leonard S. Jacob

		 		 		 		 	 Leonard S. Jacob, M.D., Ph.D.Third Amended and Restated 1996 Stock Option and Grant Plan

 Exhibit 10.1 
 THIRD AMENDED AND RESTATED 
 ANSYS, INC. 
 1996 STOCK OPTION AND GRANT PLAN 
 SECTION 1. GENERAL PURPOSE OF THE PLAN; DEFINITIONS

 The name of the plan is the Third Amended and Restated ANSYS, Inc. 1996 Stock Option and Grant Plan (the “Plan”). The purpose
of the Plan is to encourage and enable the officers, employees, directors, consultants and key persons of ANSYS, Inc. (the “Company”) and its Subsidiaries upon whose judgment, initiative and efforts the Company largely depends for the
successful conduct of its business to acquire a proprietary interest in the Company. It is anticipated that providing such persons with a direct stake in the Company’s welfare will assure a closer identification of their interests with those of
the Company, thereby stimulating their efforts on the Company’s behalf and strengthening their desire to remain with the Company. 
 The
following terms shall be defined as set forth below: 
 “Act” means the Securities Exchange Act of 1934, as amended.

 “Award” or “Awards,” except where referring to a particular category of grant under the Plan, shall
include Incentive Stock Options, Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards, Performance Share Awards, Deferred Stock Awards and Dividend Equivalent Rights. 
 “Board” means the Board of Directors of the Company. 
 “Code” means the Internal Revenue Code of 1986, as amended, and any successor Code, and related rules, regulations and interpretations. 
 “Committee” means the Committee of the Board referred to in Section 2. 
 “Deferred Stock Award” means Awards granted pursuant to Section 9. 
 “Dividend Equivalent Right” means Awards granted pursuant to Section 10. 
 “Effective Date” means the date on which the Plan is approved by stockholders as set forth in Section 16. 
 “Fair Market Value” of the Stock on any given date means (i) if the Stock is admitted to quotation on the National Association of
Securities Dealers Automated Quotation System (“NASDAQ”), the Fair Market Value on any given date shall not be less than the average of the highest bid and lowest asked prices of the Stock reported for such date or, if no bid and asked
prices were reported for such date, for the last day preceding such date for which such prices were reported, or (ii) if the Stock is admitted to trading on a national securities exchange or the NASDAQ National Market System, then clause
(i) shall not apply and the Fair Market Value on any date shall not be less than the closing price reported for the Stock on such exchange or system for such date or, if no sales were reported for such date, for the last date preceding such
date for which a sale was reported. 
 “Incentive Stock Option” means any Stock Option designated and qualified as an
“incentive stock option” as defined in Section 422 of the Code. 
 “Independent Director” means a member of
the Board who is considered an “Independent Director” as set forth in the Nasdaq listing requirements. 

 “Non-Qualified Stock Option” means any Stock Option that is not an Incentive Stock
Option. 
 “Option” or “Stock Option” means any option to purchase shares of Stock granted pursuant to
Section 5. 
 “Performance Share Award” means any Award granted pursuant to Section 8. 
 “Restricted Stock Award” means any Award granted pursuant to Section 6. 
 “Stock” means the Common Stock, par value $.01 per share, of the Company, subject to adjustments pursuant to Section 3. 

“Subsidiary” means any corporation or other entity (other than the Company) in any unbroken chain of corporations or other entities,
beginning with the Company, if each of the corporations or entities (other than the last corporation or entity in the unbroken chain) owns stock or other interests possessing 50% or more of the economic interest or the total combined voting power of
all classes of stock or other interests in one of the other corporations or entities in the chain. 
 “Unrestricted Stock
Award” means any Award granted pursuant to Section 7. 
 SECTION 2. ADMINISTRATION OF PLAN; COMMITTEE AUTHORITY TO SELECT PARTICIPANTS
AND DETERMINE AWARDS 
 (a) Committee. The Plan shall be administered by the Compensation Committee of the Board,
or any other committee of not less than two Independent Directors performing similar functions as appointed by the Board from time to time. Each member of the Committee shall be an “Outside Director” within the meaning of
Section 162(m) of the Code and the regulations promulgated thereunder. The Plan may be administered by either the Board or a committee of not less than two “Independent Directors” and all references to the “Committee” (other
than the last sentence of Section 4) shall also be deemed to refer to the Board. 
 (b) Powers of
Committee. The Committee shall have the power and authority to grant Awards consistent with the terms of the Plan, including the power and authority: 
 (i) to select the officers, employees, directors, consultants and key persons of the Company and its Subsidiaries to whom Awards may from
time to time be granted; 
 (ii) to determine the time or times of grant, and the extent, if any, of Incentive Stock Options,
Non-Qualified Stock Options, Restricted Stock Awards, Unrestricted Stock Awards, Performance Share Awards, Deferred Stock Awards and Dividend Equivalent Rights, or any combination of the foregoing, granted to any one or more participants;

 (iii) to determine the number of shares of Stock to be covered by any Award; 
 (iv) to determine and modify from time to time the terms and conditions, including restrictions, not inconsistent with the terms of the
Plan, of any Award, which terms and conditions may differ among individual Awards and participants, and to approve the form of written instruments evidencing the Awards; 
 (v) to accelerate at any time the exercisability or vesting of all or any portion of any Award and/or to include provisions in Awards
providing for such acceleration; 
 (vi) to impose any limitations on Awards granted under the Plan, including limitations on
transfers, repurchase provisions and the like; 
  

 2 

 (vii) subject to the provisions of Section 5(a)(ii), to extend at any time the
period in which Stock Options may be exercised; 
 (viii) to determine at any time whether, to what extent, and under what
circumstances Stock and other amounts payable with respect to an Award shall be deferred either automatically or at the election of the participant and whether and to what extent the Company shall pay or credit amounts constituting interest (at
rates determined by the Committee) or dividends or deemed dividends on such deferrals; and 
 (ix) at any time to adopt, alter
and repeal such rules, guidelines and practices for administration of the Plan and for its own acts and proceedings as it shall deem advisable; to interpret the terms and provisions of the Plan and any Award (including related written instruments);
to make all determinations it deems advisable for the administration of the Plan; to decide all disputes arising in connection with the Plan; and to otherwise supervise the administration of the Plan. 
 All decisions and interpretations of the Committee shall be binding on all persons, including the Company and Plan participants.

 (c) Delegation of Authority to Grant Awards. The Committee, in its discretion, may delegate to the Chief
Executive Officer of the Company all or part of the Committee’s authority and duties with respect to Awards, including the granting thereof, to individuals who are not subject to the reporting and other provisions of Section 16 of the Act
or “covered employees” within the meaning of Section 162(m) of the Code. The Committee may revoke or amend the terms of a delegation at any time but such action shall not invalidate any prior actions of the Committee’s delegate
or delegates that were consistent with the terms of the Plan. 
 SECTION 3. STOCK ISSUABLE UNDER THE PLAN; MERGERS; SUBSTITUTION 
 (a) Stock Issuable. The maximum number of shares of Stock reserved and available for issuance under the Plan shall be 12,700,000
shares of Stock. For purposes of the foregoing limitation, the shares of Stock underlying any Awards which are forfeited, canceled, held back upon exercise of an Option or settlement of an Award to cover the exercise price or tax withholdings,
reacquired by the Company prior to vesting, satisfied without the issuance of Stock or otherwise terminated (other than by exercise) shall be added back to the shares of Stock available for issuance under the Plan. No more than fifty percent
(50%) of the number of shares of Stock available for issuance under the Plan as of May 8, 2003, and as approved by the Company’s stockholders at the 2003 Annual Meeting of Stockholders (which such number shall be deemed to include any
shares of Stock that become re-available for issuance due to their forfeiture, cancellation or reacquisition by the Company after such date) may be issued in the form of non-Stock Option Awards. Subject to such overall limitation, shares of Stock
may be issued up to such maximum number pursuant to any type or types of Award; provided, however, that Stock Options with respect to no more than 600,000 shares of Stock may be granted to any one individual participant during any one calendar year
period. The shares available for issuance under the Plan may be authorized but unissued shares of Stock or shares of Stock reacquired by the Company. 
 (b) Recapitalizations. If, through or as a result of any merger, consolidation, sale of all or substantially all of the assets of the Company, reorganization, recapitalization, reclassification, stock dividend,
stock split, reverse stock split or other similar transaction, the outstanding shares of Stock are increased or decreased or are exchanged for a different number or kind of shares or other securities of the Company, or additional shares or new or
different shares or other securities of the Company or other non-cash assets are distributed with respect to such shares of Stock or other securities, the Committee shall make an appropriate or proportionate adjustment in (i) the 
  

 3 

 maximum number of shares reserved for issuance under the Plan or for the Independent Directors pursuant
to Section 5(c) of the Plan, (ii) the number of Stock Options that can be granted to any one individual participant, (iii) the number and kind of shares or other securities subject to any then outstanding Awards under the Plan, and
(iv) the price for each share subject to any then outstanding Stock Options under the Plan, without changing the aggregate exercise price (i.e., the exercise price multiplied by the number of shares) as to which such Stock Options remain
exercisable. The adjustment by the Committee shall be final, binding and conclusive. No fractional shares of Stock shall be issued under the Plan resulting from any such adjustment, but the Committee in its discretion may make a cash payment in lieu
of fractional shares. 
 (c) Mergers and Other Transactions. In the case of (i) the dissolution or
liquidation of the Company, (ii) a merger, reorganization or consolidation in which the Company is acquired by another person or entity (other than a holding company formed by the Company), (iii) the sale of all or substantially all of the
assets of the Company to an unrelated person or entity, or (iv) the sale of all of the Stock of the Company to an unrelated person or entity (in each case, a “Transaction”), the outstanding Options held by Independent Directors shall
become fully vested. Upon the effectiveness of the Transaction, the Plan and all Awards granted hereunder shall terminate, unless provision is made in connection with the Transaction for the assumption of Awards heretofore granted, or the
substitution of such Awards of new Awards of the successor entity or parent thereof, with appropriate adjustment as to the number and kind of shares and, if appropriate, the per share exercise prices, as provided in Section 3(b) above. In the
event of such termination, each optionee shall be permitted to exercise for a period of at least 15 days prior to the date of such termination (1) all options held by such optionee which are then exercisable, and (2) such number of
additional options held by such optionee, to the extent such options are not then exercisable, as may be specified in the relevant option agreement, if any. During this 15-day period, Independent Directors may exercise unvested Options that will
become fully vested upon the effectiveness of the Transaction, subject to the consummation of the Transaction. 
 Notwithstanding anything to the contrary in this Section 3(c), in the event of a Sale Event pursuant to which holders of the Stock of the Company will receive upon consummation thereof a cash payment for each share surrendered in the
Transaction, the Company shall have the right, but not the obligation, to make or provide for a cash payment to the grantees holding Options, in exchange for the cancellation thereof, in an amount equal to the difference between (A) the value
as determined by the Committee of the consideration payable per share of Stock pursuant to the Sale Event (the “Sale Price”) times the number of shares of Stock subject to outstanding Options (to the extent then exercisable at prices not
in excess of the Sale Price) and (B) the aggregate exercise price of all such outstanding Options. 
 (d) Substitute
Awards. The Committee may grant Awards under the Plan in substitution for stock and stock based awards held by employees of another corporation who become employees of the Company or a Subsidiary as the result of a merger or consolidation
of the employing corporation with the Company or a Subsidiary or the acquisition by the Company or a Subsidiary of property or stock of the employing corporation. The Committee may direct that the substitute awards be granted on such terms and
conditions as the Committee considers appropriate in the circumstances. 
 SECTION 4. ELIGIBILITY 
 Participants in the Plan will be such directors, officers and other employees, consultants and key persons of the Company and its Subsidiaries who are
responsible for or contribute to the management, growth or profitability of the Company and its Subsidiaries as are selected from time to time by the Committee, in its sole discretion. 
  

 4 

 SECTION 5. STOCK OPTIONS 
 Any Stock Option granted under the Plan shall be pursuant to a stock option agreement which shall be in such form as the Committee may from time to time approve. Option agreements need not be identical. 
 Stock Options granted under the Plan may be either Incentive Stock Options or Non-Qualified Stock Options. Incentive Stock Options may be granted only to
employees of the Company or any Subsidiary that is a “subsidiary corporation” within the meaning of Section 424(f) of the Code. Non-Qualified Stock Options may be granted to officers, employees, directors, advisors, consultants and
key persons of the Company and its Subsidiaries. To the extent that any Option does not qualify as an Incentive Stock Option, it shall be deemed a Non-Qualified Stock Option. 
 (a) Terms of Stock Options. Stock Options granted under the Plan shall be subject to the following terms and conditions and shall
contain such additional terms and conditions, not inconsistent with the terms of the Plan, as the Committee shall deem desirable: 
 (i) Exercise Price. The exercise price per share for the Stock covered by a Stock Option shall be determined by the Committee at the time of grant but shall not be less than 100% of the Fair Market Value on the date of grant in the
case of Incentive Stock Options. If an employee owns or is deemed to own (by reason of the attribution rules applicable under Section 424(d) of the Code) more than 10% of the combined voting power of all classes of stock of the Company or any
parent or subsidiary corporation and an Incentive Stock Option is granted to such employee, the option price of such Incentive Stock Option shall be not less than 110% of the Fair Market Value on the grant date. 
 (ii) Option Term. The term of each Stock Option shall be fixed by the Committee, but no Incentive Stock Option shall be exercisable
more than ten years after the date the option is granted. If an employee owns or is deemed to own (by reason of the attribution rules of Section 424(d) of the Code) more than 10% of the combined voting power of all classes of stock of the
Company or any parent or subsidiary corporation and an Incentive Stock Option is granted to such employee, the term of such option shall be no more than five years from the date of grant. 
 (iii) Exercisability; Rights of a Stockholder. Stock Options shall become vested and exercisable at such time or times, whether or
not in installments, as shall be determined by the Committee at or after the grant date. The Committee may at any time accelerate the exercisability of all or any portion of any Stock Option. An optionee shall have the rights of a stockholder only
as to shares acquired upon the exercise of a Stock Option and not as to unexercised Stock Options. 
 (iv) Method of
Exercise. Stock Options may be exercised in whole or in part, by giving written notice of exercise to the Company, specifying the number of shares to be purchased. Payment of the purchase price may be made by one or more of the following
methods: 
 (A) In cash, by certified or bank check or other instrument acceptable to the Committee; 
 (B) In the form of shares of Stock that are not then subject to restrictions under any Company plan and that have been held by the
optionee free of such restrictions for at least six months, if permitted by the Committee in its discretion. Such surrendered shares shall be valued at Fair Market Value on the exercise date; or 
  

 5 

 (C) By the optionee delivering to the Company a properly executed exercise notice
together with irrevocable instructions to a broker to promptly deliver to the Company cash or a check payable and acceptable to the Company to pay the purchase price; provided that in the event the optionee chooses to pay the purchase price as so
provided, the optionee and the broker shall comply with such procedures and enter into such agreements of indemnity and other agreements as the Committee shall prescribe as a condition of such payment procedure. 
 Payment instruments will be received subject to collection. The delivery of certificates representing the shares of Stock to be purchased
pursuant to the exercise of a Stock Option will be contingent upon receipt from the optionee (or a purchaser acting in his stead in accordance with the provisions of the Stock Option) by the Company of the full purchase price for such shares and the
fulfillment of any other requirements contained in the Stock Option or applicable provisions of laws. 
 (v)
Termination. Unless otherwise provided in the option agreement or determined by the Committee, upon the optionee’s termination of employment (or other business relationship) with the Company and its Subsidiaries, the optionee’s
rights in his Stock Options shall automatically terminate. 
 (vi) Annual Limit on Incentive Stock Options. To the
extent required for “incentive stock option” treatment under Section 422 of the Code, the aggregate Fair Market Value (determined as of the time of grant) of the shares of Stock with respect to which Incentive Stock Options granted
under this Plan and any other plan of the Company or its parent and subsidiary corporations become exercisable for the first time by an optionee during any calendar year shall not exceed $100,000. To the extent that any Stock Option exceeds this
limit, it shall constitute a Non-Qualified Stock Option. 
 (b) Reload Options. At the discretion of the
Committee, Options granted under Section 5(a) may include a “reload” feature pursuant to which an optionee exercising an option by the delivery of a number of shares of Stock in accordance with Section 5(a)(iv)(B) hereof would
automatically be granted an additional Option (with an exercise price equal to the Fair Market Value of the Stock on the date the additional Option is granted and with the same expiration date as the original Option being exercised, and with such
other terms as the Committee may provide) to purchase that number of shares of Stock equal to the number delivered to exercise the original Option. 
 (c) Grants to Directors. 
 (i) Automatic Grant. 
 (A) The Chairman of the Board of Directors (the “Chairman”), provided he or she is not an officer of the Company, and each
non-affiliate Independent Director who is serving as a director of the Company on the fifth business day after each annual meeting of stockholders shall automatically be granted either (1) a Deferred Stock Award for 3,600 deferred stock units;
or (2) Non-Qualified Stock Options to acquire 12,000 shares of Stock. 
 (B) The parties receiving an Award under
Section 5(c)(i)(A) shall elect in advance whether to receive the automatic grant as either a Deferred Stock Award or Non-Qualified Stock Options. Such election shall be made at the time and in the form as required by the Committee. 

 

 6 

 (ii) Terms. 
 (A) Deferred Stock Award. The Deferred Stock Award pursuant to this Section 5(c) shall be granted quarterly in arrears, shall be
fully vested upon grant and shall be paid to the recipient in the form of shares of Stock as soon as reasonably practicable following his or her cessation of service as a director of the Company, but in no event shall such Deferred Stock Award be
paid more than two and one-half months after the end of the year in which such cessation of service occurs. 
 (B)
Non-Qualified Stock Option. 
 (1) The Option Exercise Price per share for the Stock covered by a Stock Option granted
pursuant to this Section 5(c) shall be equal to the Fair Market Value of the Stock on the date of grant. 
 (2) Each
Stock Option granted pursuant to this Section 5(c) shall be granted quarterly in arrears, and shall be exercisable as specified by the Committee. No such Stock Option shall be exercisable after the seventh anniversary of the date it was
granted. 
 (3) If an optionee ceases to be a director for any reason, each Stock Option granted to such optionee under this
Section 5(c) shall terminate immediately with respect to all shares of Stock for which it is not then exercisable. With respect to the remaining shares, such Option shall terminate 60 days after the date the optionee ceases to be a director or
at the expiration of the stated term of the Option, if earlier; provided, however, that (1) if the optionee dies while a director, such Option may be exercised for such remaining shares by the personal representative or legatee of the optionee
for a period of one year from the date of death or until the expiration of the stated term of the Option, if earlier; or (2) if the optionee ceases to be a director by reason of disability, such Option may be exercised for such remaining shares
by the director for six months after the date the optionee ceases to be a director or until the expiration of the stated term of the Option, if earlier. 
 (4) A Stock Option granted under this Section 5(c) may be exercised only by written notice to the Company specifying the number of shares to be purchased. Payment of the full purchase price of the shares to be
purchased may be made by one or more of the methods specified in Section 5(a)(v). An optionee shall have the rights of a stockholder only as to shares acquired upon the exercise of an Option and not as to unexercised Options. 
 (iii) Limited to Chairman and Independent Directors. The provisions of this Section 5(c) shall apply only to Deferred Stock
Awards and Stock Options automatically granted or to be automatically granted under Section 5(c)(i)(A), and shall not be deemed to modify, limit or otherwise apply to any other provision of this Plan or to any Award issued under this Plan to a
participant who is not granted an Award under Section 5(c)(i)(A). To the extent that they are inconsistent with any other provisions of the Plan, the provisions of this Section 5(c) shall govern the rights and obligations of the Company
and the Chairman and Independent Directors respecting Deferred Stock Awards and Stock Options automatically granted or to be automatically granted to the Chairman and Independent Directors. 
  

 7 

 SECTION 6. RESTRICTED STOCK AWARDS 
 (a) Nature of Restricted Stock Awards. The Committee may grant Restricted Stock Awards to any officer, employee, consultant or
key person of the Company and its Subsidiaries. A Restricted Stock Award is an Award entitling the recipient to acquire, at par value or such other purchase price determined by the Committee, shares of Stock subject to such restrictions and
conditions as the Committee may determine at the time of grant (“Restricted Stock”). Conditions may be based on continuing employment (or other business relationship) and/or achievement of pre-established performance goals and objectives.

 (b) Rights as a Stockholder. Upon execution of a written instrument setting forth the Restricted Stock Award
and paying any applicable purchase price, a participant shall have the rights of a stockholder with respect to the voting of the Restricted Stock, subject to such conditions contained in the written instrument evidencing the Restricted Stock Award.
Unless the Committee shall otherwise determine, certificates evidencing the Restricted Stock shall remain in the possession of the Company until such Restricted Stock is vested as provided in Section 6(e) below. 
 (c) Restrictions. Restricted Stock may not be sold, assigned, transferred, pledged or otherwise encumbered or disposed of
except as specifically provided herein or in the written instrument evidencing the Restricted Stock Award. If a participant’s employment (or other business relationship) with the Company and its Subsidiaries terminates for any reason, the
Company or its assigns shall have the right or shall agree, as may be specified in the relevant restricted stock agreement, to repurchase Restricted Stock with respect to which conditions have not lapsed at their purchase price from the participant
or the participant’s legal representative. 
 (d) Vesting of Restricted Stock. The Committee at the time of
grant shall specify the date or dates and/or the attainment of pre-established performance goals, objectives and other conditions on which Restricted Stock shall become vested, subject to such further rights of the Company or its assigns as may be
specified in the instrument evidencing the Restricted Stock Award. 
 (e) Waiver, Deferral and Reinvestment of
Dividends. The written instrument evidencing the Restricted Stock Award may require or permit the immediate payment, waiver, deferral or investment of dividends paid on the Restricted Stock. 
 SECTION 7. UNRESTRICTED STOCK AWARDS 
 (a) Grant or Sale of Unrestricted Stock. The Committee may, in its sole discretion, grant (or sell at a purchase price determined by the Committee) an Unrestricted Stock Award to any officer, employee, consultant or key person
of the Company or its Subsidiaries, pursuant to which such individual may receive shares of Stock free of any vesting restrictions (“Unrestricted Stock”) under the Plan. Unrestricted Stock Awards may be granted or sold as described in the
preceding sentence in respect of past services or other valid consideration, or in lieu of any cash compensation due to such individual. 
 SECTION 8. PERFORMANCE SHARE AWARDS 
 (a) Nature of Performance Share Awards. A Performance
Share Award is an Award entitling the recipient to acquire shares of Stock upon the attainment of specified performance goals. The Committee may make Performance Share Awards independent of or in connection with the granting of any other Award under
the Plan. Performance Share Awards may be granted under the Plan to any officer, employee, consultant or key person of the Company or its Subsidiaries, 
  

 8 

 including those who qualify for awards under other performance plans of the Company. The Committee in its
sole discretion shall determine whether and to whom Performance Share Awards shall be made, the performance goals applicable under each such Award, the periods during which performance is to be measured, and all other limitations and conditions
applicable to the awarded Performance Shares; provided, however, that the Committee may rely on the performance goals and other standards applicable to other performance unit plans of the Company in setting the standards for Performance Share Awards
under the Plan. 
 (b) Restrictions on Transfer. Performance Share Awards and all rights with respect to such
Awards may not be sold, assigned, transferred, pledged or otherwise encumbered. 
 (c) Rights as a Shareholder. A
participant receiving a Performance Share Award shall have the rights of a shareholder only as to shares actually received by the participant under the Plan and not with respect to shares subject to the Award but not actually received by the
participant. A participant shall be entitled to receive a stock certificate evidencing the acquisition of shares of Stock under a Performance Share Award only upon satisfaction of all conditions specified in the written instrument evidencing the
Performance Share Award (or in a performance plan adopted by the Committee). 
 (d) Termination. Except as may
otherwise be provided by the Committee at any time, a participant’s rights in all Performance Share Awards shall automatically terminate upon the participant’s termination of employment (or business relationship) with the Company and its
Subsidiaries for any reason. 
 (e) Acceleration, Waiver, Etc. At any time prior to the participant’s
termination of employment (or other business relationship) by the Company and its Subsidiaries, the Committee may in its sole discretion accelerate, waive or, subject to Section 13, amend any or all of the goals, restrictions or conditions
imposed under any Performance Share Award. 
 SECTION 9. DEFERRED STOCK AWARDS 
 (a) Nature of Deferred Stock Awards. A Deferred Stock Award is an Award of phantom stock units to a grantee, subject to
restrictions and conditions as the Committee may determine at the time of grant. Conditions may be based on continuing employment (or other service relationship) and/or achievement of pre-established performance goals and objectives. The grant of a
Deferred Stock Award is contingent on the grantee executing the Deferred Stock Award agreement. The terms and conditions of each such agreement shall be determined by the Committee, and such terms and conditions may differ among individual Awards
and grantees. At the end of the deferral period, the Deferred Stock Award, to the extent vested, shall be paid to the grantee in the form of shares of Stock. 
 (b) Election to Receive Deferred Stock Awards in Lieu of Compensation. The Committee may, in its sole discretion, permit a grantee
to elect to receive a portion of future cash compensation otherwise due to such grantee in the form of a Deferred Stock Award. Any such election shall be made in writing and shall be delivered to the Company no later than the date specified by the
Committee and in accordance with Section 409A of the Code and such other rules and procedures established by the Committee. The Committee shall have the sole right to determine whether and under what circumstances to permit such elections and
to impose such limitations and other terms and conditions thereon as the Committee deems appropriate. Any such deferred compensation shall be converted to a fixed number of phantom stock units based on the Fair Market Value of Stock on the date the
compensation would otherwise have been paid to the grantee but for the deferral. 
  

 9 

 (c) Rights as a Stockholder. During the deferral period, a grantee shall have
no rights as a stockholder; provided, however, that the grantee may be credited with Dividend Equivalent Rights with respect to the phantom stock units underlying his Deferred Stock Award, subject to such terms and conditions as the Committee may
determine. 
 (d) Termination. Except as may otherwise be provided by the Committee either in the Award agreement
or, subject to Section 13 below, in writing after the Award agreement is issued, a grantee’s right in all Deferred Stock Awards that have not vested shall automatically terminate upon the grantee’s termination of employment (or
cessation of service relationship) with the Company and its Subsidiaries for any reason. 
 SECTION 10. DIVIDEND EQUIVALENT RIGHTS 
 (a) Dividend Equivalent Rights. A Dividend Equivalent Right is an Award entitling the recipient to receive credits based on
cash dividends that would be paid on the shares of Stock specified in the Dividend Equivalent Right (or other award to which it relates) if such shares were held by the recipient. A Dividend Equivalent Right may be granted hereunder to any officer,
employee, consultant or key person, as a component of another Award or as a freestanding award. The terms and conditions of Dividend Equivalent Rights shall be specified in the grant. Dividend equivalents credited to the holder of a Dividend
Equivalent Right may be paid currently or may be deemed to be reinvested in additional shares of Stock, which may thereafter accrue additional equivalents. Any such reinvestment shall be at Fair Market Value on the date of reinvestment or such other
price as may then apply under a dividend reinvestment plan sponsored by the Company, if any. Dividend Equivalent Rights may be settled in cash or shares of Stock or a combination thereof, in a single installment or installments. A Dividend
Equivalent Right granted as a component of another Award may provide that such Dividend Equivalent Right shall be settled upon exercise, settlement, or payment of, or lapse of restrictions on, such other award, and that such Dividend Equivalent
Right shall expire or be forfeited or annulled under the same conditions as such other award. A Dividend Equivalent Right granted as a component of another Award may also contain terms and conditions different from such other award. 
 (b) Interest Equivalents. Any Award under this Plan that is settled in whole or in part in cash on a deferred basis may
provide in the grant for interest equivalents to be credited with respect to such cash payment. Interest equivalents may be compounded and shall be paid upon such terms and conditions as may be specified by the grant. 
 SECTION 11. TAX WITHHOLDING 
 Each participant
shall, no later than the date as of which the value of an Award or of any Stock or other amounts received thereunder first becomes includable in the gross income of the participant for Federal income tax purposes, pay to the Company, or make
arrangements satisfactory to the Committee regarding payment of, any federal, state, or local taxes of any kind required by law to be withheld with respect to such income. The Company and its Subsidiaries shall, to the extent permitted by law, have
the right to deduct any such taxes from any payment of any kind otherwise due to the participant. 
 SECTION 12. TRANSFER, LEAVE OF ABSENCE, ETC.

 For purposes of the Plan, the following events shall not be deemed a termination of employment: 
 (a) a transfer to the employment of the Company from a Subsidiary or from the Company to a Subsidiary, or from one Subsidiary to another;
or 
  

 10 

 (b) an approved leave of absence for military service or sickness, or for any other
purpose approved by the Company, if the employee’s right to re-employment is guaranteed either by a statute or by contract or under the policy pursuant to which the leave of absence was granted or if the Committee otherwise so provides in
writing. 
 SECTION 13. AMENDMENTS AND TERMINATION 
 The Board may, at any time, amend or discontinue the Plan and the Committee may, at any time, amend or cancel any outstanding Award (or provide substitute Awards at the same exercise or purchase price in a manner not
inconsistent with the terms of the Plan), but such price, if any, must satisfy the requirements which would apply to the substitute or amended Award if it were then initially granted under this Plan for the purpose of satisfying changes in law or
for any other lawful purpose, but no such action shall adversely affect rights under any outstanding Award without the holder’s consent. Notwithstanding any other provision of this Plan to the contrary, no outstanding Option under the Plan may
be re-priced, either by amendment to the Option or by cancellation of the Option in exchange for the grant of a new Option with a lower exercise price, without the prior approval by the Company’s stockholders who are eligible to vote at a
meeting of stockholders. If and to the extent determined by the Committee to be required by the Act to ensure that Awards granted under the Plan are exempt under Rule 16b-3 promulgated under the Act, or that Incentive Stock Options granted under the
Plan are qualified under Section 422 of the Code, Plan amendments shall be subject to approval by the Company’s stockholders who are eligible to vote at a meeting of stockholders. Any material Plan amendments shall be subject to
shareholder approval to the extent required by Rule 4350(i) of the Nasdaq Stock Market, Inc., as such rule may be amended and interpreted from time to time. 
 SECTION 14. STATUS OF PLAN 
 With respect to the portion of any Award which has not been exercised and any payments in
cash, Stock or other consideration not received by a participant, a participant shall have no rights greater than those of a general creditor of the Company unless the Committee shall otherwise expressly determine in connection with any Award or
Awards. In its sole discretion, the Committee may authorize the creation of trusts or other arrangements to meet the Company’s obligations to deliver Stock or make payments with respect to Awards hereunder, provided that the existence of such
trusts or other arrangements is consistent with the foregoing sentence. 
 SECTION 15. GENERAL PROVISIONS 
 (a) No Distribution; Compliance with Legal Requirements. The Committee may require each person acquiring Stock pursuant to an
Award to represent to and agree with the Company in writing that such person is acquiring the shares without a view to distribution thereof. 
 No shares of Stock shall be issued pursuant to an Award until all applicable securities law and other legal and stock exchange or similar requirements have been satisfied. The Committee may require the placing of such
stop-orders and restrictive legends on certificates for Stock and Awards as it deems appropriate. 
 (b) Other Compensation
Arrangements; No Employment Rights. Nothing contained in this Plan shall prevent the Board from adopting other or additional compensation arrangements, including trusts, and such arrangements may be either generally applicable or applicable
only in specific cases. The adoption of this Plan and the grant of Awards do not confer upon any employee any right to continued employment with the Company or any Subsidiary. 
  

 11 

 SECTION 16. EFFECTIVE DATE OF PLAN 
 This Plan shall become effective upon approval by the holders of a majority of the shares of Stock of the Company present or represented and entitled to
vote at a meeting of stockholders. Subject to such approval by the stockholders and to the requirement that no Stock may be issued hereunder prior to such approval, Stock Options and other Awards may be granted hereunder on and after adoption of
this Plan by the Board. No grants of Stock Options and other Awards may be made hereunder after June 15, 2016. 
 SECTION 17. GOVERNING LAW

 This Plan shall be governed by Delaware law except to the extent such law is preempted by federal law. 
  

 12

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00105-of-00352.parquet"}]]